Sharon Schwartz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sharon Schwartz has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Nicolle M. Gatto
Department of Epidemiology, Columbia University, Mailman School of Public Health, New York, NY; Epidemiology, Worldwide Safety and Regulatory, Pfizer Inc, New York, NY
3 shared publicationsUlka B. Campbell
Department of Epidemiology, Columbia University, Mailman School of Public Health, New York, NY; Epidemiology, Worldwide Safety and Regulatory, Pfizer Inc, New York, NY
3 shared publicationsE. Susser
Mailman School of Public Health, Columbia University, New York, NY, USA
2 shared publications- Nicolle M. Gatto
Aetion New York New York USA
2 shared publications Seth J. Prins
Department of Epidemiology, Columbia University, Mailman School of Public Health, USA
2 shared publications- Ulka B. Campbell
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032 USA
2 shared publications
Latest Publications
- 1 June 2017
- Published by Elsevier in Annals of Epidemiology
- Vol. 27 (6) , 402-405
Heeding the call for less casual causal inferences: the utility of realized (quantitative) causal effects
- 1 June 2017
- Published by Elsevier in Annals of Epidemiology
- Vol. 27 (6) , 402-405
Heeding the call for less casual causal inferences: the utility of realized (quantitative) causal effects
- 8 February 2017
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 52 (2) , 139-142
Commentary: on the application of potential outcomes-based methods to questions in social psychiatry and psychiatric epidemiology
- 8 February 2017
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 52 (2) , 139-142
Commentary: on the application of potential outcomes-based methods to questions in social psychiatry and psychiatric epidemiology
- 1 October 2016
- Published by Elsevier in Annals of Epidemiology
- Vol. 26 (10) , 669-673
Causal identification: a charge of epidemiology in danger of marginalization
- 1 October 2016
- Published by Elsevier in Annals of Epidemiology
- Vol. 26 (10) , 669-673
Causal identification: a charge of epidemiology in danger of marginalization
- 1 October 2016
- Published by Elsevier in Social Science & Medicine
- Vol. 166, 254-257
Is the “well-defined intervention assumption” politically conservative?
- 1 October 2016
- Published by Elsevier in Social Science & Medicine
- Vol. 166, 254-257
Is the “well-defined intervention assumption” politically conservative?
- Open Access
- 1 January 2016
- Published by American Psychological Association (APA) in American Journal of Orthopsychiatry
- Vol. 86 (5) , 477-485
Weighing the evidence for harm from long-term treatment with antipsychotic medications: A systematic review.
Research findings supporting the use of antipsychotic medication for acute treatment of schizophrenia are relatively consistent and undisputed. However, the rationale for recommending long-term antipsychotic medication treatment-the current standard of care treatment strategy-is unclear. A controversial hypothesis proposed recently suggests people with schizophrenia who are exposed to long-term treatment with antipsychotic medications have worse outcomes than people with schizophrenia who are not exposed to these medications. We tested whether a systematic appraisal of published literature would produce data consistent with this hypothesis. We reviewed the published literature to identify studies of patients with psychotic disorders who were followed for at least 2 years that compared outcomes in patients who received antipsychotic medication during the follow-up with patients who did not receive antipsychotic medication during the follow-up. We included all English language articles published through 2013 in this review. Our process for selecting studies and documenting study findings included a consensus decision of 2 members of the research team. We found the published data to be inadequate to test this hypothesis. By extension, these data were also inadequate to conclusively evaluate whether long-term antipsychotic medication treatment results in better outcomes on average. We conclude that careful reappraisal of existing data is useful to ensure standard of care treatment strategies are indeed evidence-based. In the case of long-term use of antipsychotic medications, new data may be needed to establish a sufficient evidence base to understand its benefit/risk balance for patients with schizophrenia. (PsycINFO Database Record
- 1 January 2016
- Published by American Psychological Association (APA) in American Journal of Orthopsychiatry
- Vol. 86 (5) , 477-485
Open AccessWeighing the evidence for harm from long-term treatment with antipsychotic medications: A systematic review.
Research findings supporting the use of antipsychotic medication for acute treatment of schizophrenia are relatively consistent and undisputed. However, the rationale for recommending long-term antipsychotic medication treatment-the current standard of care treatment strategy-is unclear. A controversial hypothesis proposed recently suggests people with schizophrenia who are exposed to long-term treatment with antipsychotic medications have worse outcomes than people with schizophrenia who are not exposed to these medications. We tested whether a systematic appraisal of published literature would produce data consistent with this hypothesis. We reviewed the published literature to identify studies of patients with psychotic disorders who were followed for at least 2 years that compared outcomes in patients who received antipsychotic medication during the follow-up with patients who did not receive antipsychotic medication during the follow-up. We included all English language articles published through 2013 in this review. Our process for selecting studies and documenting study findings included a consensus decision of 2 members of the research team. We found the published data to be inadequate to test this hypothesis. By extension, these data were also inadequate to conclusively evaluate whether long-term antipsychotic medication treatment results in better outcomes on average. We conclude that careful reappraisal of existing data is useful to ensure standard of care treatment strategies are indeed evidence-based. In the case of long-term use of antipsychotic medications, new data may be needed to establish a sufficient evidence base to understand its benefit/risk balance for patients with schizophrenia. (PsycINFO Database Record
- Open Access
- 3 April 2012
- Published by Springer Nature in Epidemiologic Perspectives & Innovations
- Vol. 9 (1) , 3
Extending the sufficient component cause model to describe the Stable Unit Treatment Value Assumption (SUTVA)
Causal inference requires an understanding of the conditions under which association equals causation. The exchangeability or no confounding assumption is well known and well understood as central to this task. More recently the epidemiologic literature has described additional assumptions related to the stability of causal effects. In this paper we extend the Sufficient Component Cause Model to represent one expression of this stability assumption--the Stable Unit Treatment Value Assumption. Approaching SUTVA from an SCC model helps clarify what SUTVA is and reinforces the connections between interaction and SUTVA.
- 3 April 2012
- Published by Springer Nature in Epidemiologic Perspectives & Innovations
- Vol. 9 (1) , 3
Open AccessExtending the sufficient component cause model to describe the Stable Unit Treatment Value Assumption (SUTVA)
Causal inference requires an understanding of the conditions under which association equals causation. The exchangeability or no confounding assumption is well known and well understood as central to this task. More recently the epidemiologic literature has described additional assumptions related to the stability of causal effects. In this paper we extend the Sufficient Component Cause Model to represent one expression of this stability assumption--the Stable Unit Treatment Value Assumption. Approaching SUTVA from an SCC model helps clarify what SUTVA is and reinforces the connections between interaction and SUTVA.
- 1 September 2010
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 41 (6) , 1127-1131
The use of well controls: an unhealthy practice in psychiatric research
Background: Studies comparing cases with controls to uncover the causes of psychiatric disorders are common in biological research. The validity of these studies depends upon adherence to the methodological principles underlying the case-control design. However, these principles are often violated. One common practice that violates these principles is the use of well controls. In this paper we describe the bias that it can cause and discuss why the use of well controls leads to invalidity in case-control studies.Method: Using hypothetical numerical examples we illustrate the consequences of using well controls.Results: The results illustrate that the use of well controls can cause substantial bias. In no instance does the use of well controls improve validity.Conclusions: We conclude that the use of well controls is an unhealthy practice in psychiatric research.
- 1 September 2010
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 41 (6) , 1127-1131
The use of well controls: an unhealthy practice in psychiatric research
Background: Studies comparing cases with controls to uncover the causes of psychiatric disorders are common in biological research. The validity of these studies depends upon adherence to the methodological principles underlying the case-control design. However, these principles are often violated. One common practice that violates these principles is the use of well controls. In this paper we describe the bias that it can cause and discuss why the use of well controls leads to invalidity in case-control studies.Method: Using hypothetical numerical examples we illustrate the consequences of using well controls.Results: The results illustrate that the use of well controls can cause substantial bias. In no instance does the use of well controls improve validity.Conclusions: We conclude that the use of well controls is an unhealthy practice in psychiatric research.
- Open Access
- 26 August 2010
- Published by Springer Nature in Epidemiologic Perspectives & Innovations
- Vol. 7 (1) , 7
Author's response to Poole, C. Commentary: How Many Are Affected? A Real Limit of Epidemiology
- 26 August 2010
- Published by Springer Nature in Epidemiologic Perspectives & Innovations
- Vol. 7 (1) , 7
Open AccessAuthor's response to Poole, C. Commentary: How Many Are Affected? A Real Limit of Epidemiology
- 1 April 2010
- Published by Elsevier in Social Science & Medicine
- Vol. 70 (8) , 1111-1118
Mental health disparities research: The impact of within and between group analyses on tests of social stress hypotheses
- 1 April 2010
- Published by Elsevier in Social Science & Medicine
- Vol. 70 (8) , 1111-1118
Mental health disparities research: The impact of within and between group analyses on tests of social stress hypotheses
- Open Access
- 3 November 2009
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 39 (5) , 1399-1401
Author's Response
We read with interest Jay Kaufman's1 commentary on our paper, ‘Opening the black box: a motivation for the assessment of mediation’,2 in which he takes us to task for focusing on natural effects (i.e. description of how the exposure influenced the disease through the mediator), rather than controlled effects (i.e. estimates of the effect of intervention on the mediator). Kaufman's critique raises an important problem that goes well beyond mediation—the relationship between aetiological research and the goal of improving the public health. We welcome this opportunity to clarify our perspective.
- 3 November 2009
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 39 (5) , 1399-1401
Open AccessAuthor's Response
We read with interest Jay Kaufman's1 commentary on our paper, ‘Opening the black box: a motivation for the assessment of mediation’,2 in which he takes us to task for focusing on natural effects (i.e. description of how the exposure influenced the disease through the mediator), rather than controlled effects (i.e. estimates of the effect of intervention on the mediator). Kaufman's critique raises an important problem that goes well beyond mediation—the relationship between aetiological research and the goal of improving the public health. We welcome this opportunity to clarify our perspective.